The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
Phones:
+7 (495) 482-4118
+7 (495) 482-4329
  • Toll-free number for subscriptions:
    +8 800 250-18-12
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Safina D.R.

Kazan Federal University

Gismatullina E.I.

Kazan (Volga region) Federal University

Esin R.G.

Kazan State Medical Academy;
Kazan (Volga region) Federal University

Cerebral venous thrombosis associated with COVID-19

Authors:

Safina D.R., Gismatullina E.I., Esin R.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(9): 128‑131

DOI: 10.17116/jnevro2022122091128

Read: 2543 times

Contact the author
Table of contents

CEREBRAL VENOUS THROMBOSIS ASSOCIATED WITH COVID-19
CEREBRAL VENOUS THROMBOSIS ASSOCIATED WITH COVID-19

To cite this article:

Safina DR, Gismatullina EI, Esin RG. Cerebral venous thrombosis associated with COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(9):128‑131. (In Russ.)
https://doi.org/10.17116/jnevro2022122091128

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sleep diso­rders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132
Cere­bral venous thro­mbosis in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):11-19
Effe­ctiveness and tole­rability of agomelatine (Valdoxan) in the treatment of depression after COVID-19 (TELESFOR study). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):90-98
Cere­bral venous thro­mbosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):36-42
Atte­ndance of dental surgeons for diseases in the Russian Fede­ration in 2017—2023. Stomatology. 2025;(4):62-65
Sarcoid reaction with focal inte­rstitial fibrosis in a COVID-19 patient with persistence of Sars-Cov-2 virus nucleocapsid and adhe­sion proteins in sarcoid granulomas and lung tissue. Russian Journal of Archive of Pathology. 2025;(4):54-57
Features of lung cancer carcinogenesis invo­lving cancer stem cells in COVID-19. Effe­cts of photodynamic therapy in the treatment of cancer and COVID-19. Russian Journal of Archive of Pathology. 2025;(5):65-73
Multimorbidity, risk factors and causes of death in patients with cardiovascular diseases during long-term posthospital moni­toring. Russian Journal of Preventive Medi­cine. 2025;(11):36-44
Coro­naviruses in human pathophysiology: a brief history of the COVID-19 pandemic. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):55-63
Poly­morphic variants of IL23R, IL6, IL28B, IL17F genes in patients who have survived after coro­navirus SARS-CoV-2 infe­ction. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):129-134
Abstract:

The literature reports that cerebral venous thrombosis (CVT) develops in 1—1.5% of patients with COVID-19. Recently, a new syndrome named vaccine-induced immune thrombotic thrombocytopenia (VITT) has been described. VITT is a rare side-effect of COVID-19 vaccination that also causes CVT. The article presents an overview of the above problem and a clinical case of a patient with CVT that developed within a month after the first component of the Sputnik V vaccination and COVID-19.

Keywords:

COVID-19
vaccine-induced immune thrombotic thrombocytopenia
cerebral venous thrombosis

Authors:

Safina D.R.

Kazan Federal University

Gismatullina E.I.

Kazan (Volga region) Federal University

Esin R.G.

Kazan State Medical Academy;
Kazan (Volga region) Federal University

Received:

27.03.2022

Accepted:

29.03.2022

Close metadata

References:

  1. «COVID-19 Map.». Johns Hopkins Coronavirus Resource Center. Johns Hopkins Centers for Civic Impact; 2020. coronavirus.jhu.edu/map.html
  2. Abdalkader M, Shaikh SP, Siegler JE, et al. Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature. J Stroke Cerebrovasc Dis. 2021;30(6):105733. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105733
  3. Al-Mufti F, Amuluru K, Sahni R, et al. Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study. AJNR Am J Neuroradiol. 2021;42(7):1196-1200. https://doi.org/10.3174/ajnr.A7134
  4. Wang HY, Li XL, Yan ZR, et al. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord. 2020;13:1756286420917830. https://doi.org/10.1177/1756286420917830
  5. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690.  https://doi.org/10.1001/jamaneurol.2020.1127
  6. Siegler JE, Cardona P, Arenillas JF, et al. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry. Int J Stroke. 2021;16(4):437-447.  https://doi.org/10.1177/1747493020959216
  7. Nogueira RG, Abdalkader M, Qureshi MM, et al. Global impact of COVID-19 on stroke care. Int J Stroke. 2021;16(5):573-584.  https://doi.org/10.1177/1747493021991652
  8. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352(17):1791-1798. https://doi.org/10.1056/NEJMra042354
  9. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-2040. https://doi.org/10.1182/blood.2020006000
  10. Tu TM, Goh C, Tan YK, et al. Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review. J Stroke Cerebrovasc Dis. 2020;29(12):105379. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105379
  11. Baud D, Qi X, Nielsen-Saines K, et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773.  https://doi.org/10.1016/S1473-3099(20)30195-X
  12. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6(2):162-170.  https://doi.org/10.1016/S1474-4422(07)70029-7
  13. Ortega-Gutierrez S, Holcombe A, Aksan N, et al. Association of admission clinical predictors and functional outcome in patients with Cerebral Venous and Dural Sinus Thrombosis. Clin Neurol Neurosurg. 2020;188:105563. https://doi.org/10.1016/j.clineuro.2019.105563
  14. Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-670.  https://doi.org/10.1161/01.STR.0000117571.76197.26
  15. Mowla A, Shakibajahromi B, Shahjouei S, et al. Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series. J Neurol Sci. 2020;419:117183. https://doi.org/10.1016/j.jns.2020.117183
  16. Dakay K, Cooper J, Bloomfield J, et al. Cerebral Venous Sinus Thrombosis in COVID-19 infection: a case series and review of the literature. J Stroke Cerebrovasc Dis. 2021;30(1):105434. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105434
  17. Cavalcanti DD, Raz E, Shapiro M, et al. Cerebral Venous Thrombosis Associated with COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1370-1376. https://doi.org/10.3174/ajnr.A6644
  18. Hameed S, Wasay M, Soomro B.A, et al. Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study. Cerebrovasc Dis Extra. 2021;11(2):55-60.  https://doi.org/10.1159/000516641
  19. Perry RJ, Tamborska A, Singh B, et al. CVT After Immunisation Against COVID-19 (CAIAC) collaborators. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet. 2021;398(10306):1147-1156. https://doi.org/10.1016/S0140-6736(21)01608-1
  20. https://congress-med.ru/assets/files/2021/2021-rukovodstvo-isth-po-vyiyavleniyu-i-lecheniyu-trombozov-posle-vakczinaczii-ot-covid.pdf  and-treatment-of-thrombosis-after-vaccination-from-covid.pdf
  21. Ferro JM, Coutinho JM, Dentali F, et al. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA Neurol. 2019;76(12):1457-1465. https://doi.org/10.1001/jamaneurol.2019.2764
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.